ProShares UltraShort Nasdaq Biotechnology Price & Performance (BIS)

The ProShares UltraShort Nasdaq Biotechnology ETF (BIS) has seen a surge in investor interest, hitting a recent high of $21.81 and experiencing significant inflows. Despite the bullish sentiment on declining biotech stocks, technical indicators suggest a possible short-term correction as the ETF enters overbought territory.123

ProShares UltraShort Materials (SMN) climbed 1.81% to $16.33, with a notable 22% increase in page views this week. The ETF is drawing attention amid heightened volatility in the materials sector, reflecting investor caution and tactical positioning as traders monitor sector performance and broader economic signals.4

Short interest in the ProShares UltraShort Nasdaq Biotechnology ETF (BIS) grew by 18.6% in March, reaching 8,300 shares. The ETF’s recent dividend cut and its 52-week price range highlight ongoing volatility, with investors closely watching biotech sector trends and seeking tactical hedges in uncertain markets.56